227 related articles for article (PubMed ID: 27619624)
1. Identification of B-cell epitopes of Borrelia burgdorferi outer surface protein C by screening a phage-displayed gene fragment library.
Pulzova L; Flachbartova Z; Bencurova E; Potocnakova L; Comor L; Schreterova E; Bhide M
Microbiol Immunol; 2016 Oct; 60(10):669-677. PubMed ID: 27619624
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response.
Earnhart CG; Buckles EL; Dumler JS; Marconi RT
Infect Immun; 2005 Dec; 73(12):7869-77. PubMed ID: 16299277
[TBL] [Abstract][Full Text] [Related]
3. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
Lovrich SD; Jobe DA; Schell RF; Callister SM
Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
[TBL] [Abstract][Full Text] [Related]
4. Inferring epitopes of a polymorphic antigen amidst broadly cross-reactive antibodies using protein microarrays: a study of OspC proteins of Borrelia burgdorferi.
Baum E; Randall AZ; Zeller M; Barbour AG
PLoS One; 2013; 8(6):e67445. PubMed ID: 23826301
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a unique borreliacidal epitope on the outer surface protein C of Borrelia burgdorferi.
Yang X; Li Y; Dunn JJ; Luft BJ
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):64-74. PubMed ID: 16965353
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to OspC, OspF and C6 antigens as indicators for infection with Borrelia burgdorferi in horses.
Wagner B; Goodman LB; Rollins A; Freer HS
Equine Vet J; 2013 Sep; 45(5):533-7. PubMed ID: 23432019
[TBL] [Abstract][Full Text] [Related]
7. C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease.
Jobe DA; Lovrich SD; Schell RF; Callister SM
Clin Diagn Lab Immunol; 2003 Jul; 10(4):573-8. PubMed ID: 12853388
[TBL] [Abstract][Full Text] [Related]
8. Persistent Anti-
Markowicz M; Reiter M; Gamper J; Stanek G; Stockinger H
Microbiol Spectr; 2021 Dec; 9(3):e0102021. PubMed ID: 34937165
[TBL] [Abstract][Full Text] [Related]
9. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA.
Ding W; Huang X; Yang X; Dunn JJ; Luft BJ; Koide S; Lawson CL
J Mol Biol; 2000 Oct; 302(5):1153-64. PubMed ID: 11183781
[TBL] [Abstract][Full Text] [Related]
10. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.
Wagner B; Freer H; Rollins A; Erb HN
Vet Immunol Immunopathol; 2011 Apr; 140(3-4):190-8. PubMed ID: 21208663
[TBL] [Abstract][Full Text] [Related]
11. Specific immune response to a synthetic peptide derived from outer surface protein C of Borrelia burgdorferi predicts protective borreliacidal antibodies.
Ikushima M; Matsui K; Yamada F; Kawahashi S; Nishikawa SK
FEMS Immunol Med Microbiol; 2000 Sep; 29(1):15-21. PubMed ID: 10967255
[TBL] [Abstract][Full Text] [Related]
12. Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.
Wagner B; Freer H; Rollins A; Erb HN; Lu Z; Gröhn Y
Vet Immunol Immunopathol; 2011 Dec; 144(3-4):374-81. PubMed ID: 21890217
[TBL] [Abstract][Full Text] [Related]
13. Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early lyme disease.
Arnaboldi PM; Seedarnee R; Sambir M; Callister SM; Imparato JA; Dattwyler RJ
Clin Vaccine Immunol; 2013 Apr; 20(4):474-81. PubMed ID: 23365204
[TBL] [Abstract][Full Text] [Related]
14. Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development.
Buckles EL; Earnhart CG; Marconi RT
Clin Vaccine Immunol; 2006 Oct; 13(10):1162-5. PubMed ID: 17028218
[TBL] [Abstract][Full Text] [Related]
15. An octavalent lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences.
Earnhart CG; Marconi RT
Hum Vaccin; 2007; 3(6):281-9. PubMed ID: 17921702
[TBL] [Abstract][Full Text] [Related]
16. Improved Serodiagnostic Performance for Lyme Disease by Use of Two Recombinant Proteins in Enzyme-Linked Immunosorbent Assay Compared to Standardized Two-Tier Testing.
Bradshaw GL; Thueson RK; Uriona TJ
J Clin Microbiol; 2017 Oct; 55(10):3046-3056. PubMed ID: 28768731
[TBL] [Abstract][Full Text] [Related]
17. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.
LaFleur RL; Dant JC; Wasmoen TL; Callister SM; Jobe DA; Lovrich SD; Warner TF; Abdelmagid O; Schell RF
Clin Vaccine Immunol; 2009 Feb; 16(2):253-9. PubMed ID: 19052162
[TBL] [Abstract][Full Text] [Related]
18. Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC.
Jobe DA; Lovrich SD; Asp KE; Mathiason MA; Albrecht SE; Schell RF; Callister SM
Clin Vaccine Immunol; 2008 Jun; 15(6):981-5. PubMed ID: 18417666
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses.
Izac JR; Camire AC; Earnhart CG; Embers ME; Funk RA; Breitschwerdt EB; Marconi RT
Vaccine; 2019 Apr; 37(17):2401-2407. PubMed ID: 30922701
[TBL] [Abstract][Full Text] [Related]
20. Epitope mapping of Borrelia burgdorferi OspC protein in homodimeric fold.
Norek A; Janda L
Protein Sci; 2017 Apr; 26(4):796-806. PubMed ID: 28142214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
